Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

Data as of Oct 17
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 3
Quarter 4
Quarter 1
Quarter 2
Revenue and IncomeNet Revenues309.0K299.0K396.0K356.0K
Depreciation And Amortization28.0K12.0K23.0K23.0K
Operating ExpensesGross Income----------
General Expenses6.1M4.3M5.8M5.9M
Research And Development4.6M2.5M4.3M4.5M
Total Operating Expenses6.1M4.3M5.8M5.9M
Non-Operating ExpensesOperating Income-5.8M-4.0M-5.4M-5.6M
Extraordinary Charge0.00---47.0K-44.0K
Other Expenses41.0K-53.0K10.0K-17.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.7M-4.0M-5.4M-5.6M
Income Taxes-730.0K-452.0K-569.0K-816.0K
Preferred Dividend-724.0K-50.0K-50.0K-50.0K
Discontinued Operations12.0K15.0K8.0K7.0K
Net Income-5.0M-3.6M-4.9M-4.8M
Shares To Calculate EPSShares To Calculate EPS17.8M19.0M19.5M22.6M
Shares To Calculate EPS Diluted17.8M19.0M19.5M22.6M
Earnings Per ShareEPS-$0.32-$0.19-$0.25-$0.22
EPS Diluted-$0.32-$0.19-$0.25-$0.22

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.